Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can blood tests predict who will do their swallowing exercises?

NCT ID NCT03010150

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at why people with head and neck cancer follow (or don't follow) swallowing exercises after radiation. Researchers will use blood tests and questionnaires to see if immune system proteins or feelings about the disease affect exercise habits. The goal is to find ways to help patients stick with these exercises to prevent future swallowing problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 471 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2016

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with head and neck cancer

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases * Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer * Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis * Are stage II-IVb for laryngeal cancer * Are stage I-IVb for hypopharyngeal * Are stage I-IVb for nasopharyngeal cancer * Have stage I-III unknown primary cancer with cervical Exclusion Criteria: * Have other cancer diagnoses, except non-melanoma skin cancer * Had treatment for previous head and neck cancer or radiation to the head and neck * Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy) * Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carcinoma of unknown primary are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carcinoma of unknown primary Clinical stage I HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Clinical stage II HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Clinical stage III HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Metastatic head and neck carcinoma Metastatic malignant neoplasm in the uterine cervix Pathologic stage I HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Pathologic stage II HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Pathologic stage III HPV-mediated (P16-positive) oropharyngeal carcinoma ajcc V8 Stage I hypopharyngeal carcinoma ajcc V8 Stage I nasopharyngeal carcinoma ajcc V8 Stage II hypopharyngeal carcinoma ajcc V8 Stage II laryngeal cancer ajcc V8 Stage II nasopharyngeal carcinoma ajcc V8 Stage II oropharyngeal (P16-negative) carcinoma ajcc V8 Stage III hypopharyngeal carcinoma ajcc V8 Stage III laryngeal cancer ajcc V8 Stage III nasopharyngeal carcinoma ajcc V8 Stage III oropharyngeal (P16-negative) carcinoma ajcc V8 Stage IV hypopharyngeal carcinoma ajcc V8 Stage IV laryngeal cancer ajcc V8 Stage IV nasopharyngeal carcinoma ajcc V8 Stage IV oropharyngeal (P16-negative) carcinoma ajcc V8 Stage IVA hypopharyngeal carcinoma ajcc V8 Stage IVA laryngeal cancer ajcc V8 Stage IVA nasopharyngeal carcinoma ajcc V8 Stage IVA oropharyngeal (P16-negative) carcinoma ajcc V8 Stage IVB hypopharyngeal carcinoma ajcc V8 Stage IVB laryngeal cancer ajcc V8 Stage IVB nasopharyngeal carcinoma ajcc V8 Stage IVB oropharyngeal (P16-negative) carcinoma ajcc V8

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.